4.5 Article

MicroRNA-135a and-200b, potential Biomarkers for Alzheimer's disease, regulate β secretase and amyloid precursor protein

Journal

BRAIN RESEARCH
Volume 1583, Issue -, Pages 55-64

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2014.04.026

Keywords

Alzheimer's disease; Amyloid precursor protein; beta secretase; microRNA

Categories

Funding

  1. Natural Science Foundation of China [81271924]
  2. Research Fund for the Doctoral Program of Higher Education of China [20121107110001]

Ask authors/readers for more resources

Amyloid precursor protein (APP) and beta-site amyloid precursor protein cleaving enzyme (BACE-1) play important roles in the generation of Alzheimer's disease (AD), a progressive neurodegenerative disorder. In the present study, microRNA (miR) microarray was used to analyze the miR expression profiles in the hippocampi from APP/PS1 transgenic and wild type mice. The miRs with significant alteration and putative targets on APP or BACE-1 were retrieved (miR-135a, -200b and -429). The deregulations of these miRs were confirmed in mice and further verified in AD patient samples by qPCR. Primary mouse hippocampal neurons, SH-SY5Y and HEK293 cells were used to study the function of miRs on APP and BACE-1. We found that miR-135a, which was downregulated significantly in hippocampi from APP/PS1 transgenic mice compared with the wild type control, directly interacted with the 3'-UTR of BACE-1 and repressed its expression and activity. On the other hand; miR-200b and -429, which were downregulated significantly in hippocampi from APP/PS1 transgenic mice compared with the wild type control, targeted the 3'-UTR of APP and repressed its expression. Furthermore, A beta 42 could downregulate miR-200b expression which may generate a vicious cycle resulted in accumulating A beta 42. The levels of miR-135a and -200b in the serum of DAT group were significantly lower than that of control groups (P<0.05). The serum miR-200b level of MCI group was higher than that of DAT group (P<0.05) and lower than that of control group (P<0.05). We also found decreased miR-135a and -200b levels in the cerebrospinal fluid of DAT group compared with the control group (P<0.05). In conclusion, these findings showed that miR-135a, -200b and -429 may take part in the progress of AD; miR-200b was of great potential as noninvasive and easily detected blood-based biomarkers of MCI and DAT patients. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available